Newly developed drugs for hepatocellular carcinoma expanded the use of systemic therapy: An interrupted time series analysis using an electronic medical record in Japan
{{output}}
Introduction: Systemic therapy options for hepatocellular carcinoma (HCC) have rapidly expanded, transforming the treatment landscape. However, real-world changes in treatment choices remain unclear. This study aimed to determine... ...
